Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX

OrbiMed Genesis GP LLC bought 950,000 Adarx Pharmaceuticals, Inc. shares (Form 4)

Traded Sep 28, 2026 · Filed Sep 30, 2026

On Sep 28, 2026, OrbiMed Genesis GP LLC (Director, 10% owner) bought 950,000 Adarx Pharmaceuticals, Inc. shares at US$17.00 for US$16.1M, leaving 588,235 shares. Filed Sep 30, 2026 (Form 4).

Bought
950,000 shares
Price
US$17.00
Value
US$16.1M
Holding after
588,235 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 28, 2026Common StockConversion10,690,53010,690,530Indirect
Sep 28, 2026Common StockConversion2,000,96212,691,492Indirect
Sep 28, 2026Common StockConversion769,60113,461,093Indirect
Sep 28, 2026Common StockConversion564,18714,025,280Indirect
Sep 28, 2026Common StockBuy300,249US$17.0014,325,529Indirect
Sep 28, 2026Common StockConversion7,127,0197,127,019Indirect
Sep 28, 2026Common StockConversion1,333,9758,460,994Indirect
Sep 28, 2026Common StockConversion513,0678,974,061Indirect
Sep 28, 2026Common StockConversion256,4489,230,509Indirect
Sep 28, 2026Common StockBuy61,516US$17.009,292,025Indirect
Sep 28, 2026Common StockBuy588,235US$17.00588,235Indirect

Source

View original at SEC

Related